A multicenter study led by Prof. Shuixing Zhang and Prof. Bin Zhang from the First Affiliated Hospital of Jinan University enrolled 246 patients with locally advanced NPC treated with immunotherapy. By applying artificial intelligence algorithms, the team extracted and selected optimal radiomic features from medical imaging to construct a predictive model.

The University of Osaka scientists have developed a safe, efficient “dump-and-stir” method to introduce ortho-carborane into various aromatic compounds using a newly designed lithium–copper reagent. This innovation overcomes the complexity and hazards of previous methods, paving the way for new applications in boron neutron capture therapy (BNCT), three-dimensional aromatic materials, and bioisosteric drug design.

A major international study has uncovered a new vulnerability in prostate cancer cells that could help improve treatment for one of the most common cancers affecting men.

Dana-Farber Cancer Institute researchers are leading four studies with important new findings in breast cancer, lung cancer, and bladder cancer at the European Society for Medical Oncology (ESMO) Congress 2025 in Berlin, Germany. The studies will be presented both in-person and online from October 17 to October 21. 

Dana-Farber investigators will also present clinical trial results that report improved quality of life for metastatic breast cancer patients; new approaches, based on early investigations, to using blood tests to guide the treatment of kidney cancer; and new ways to analyze real-world data with artificial intelligence.